Sickle Cell at UI Health
For more than 50 years, UI Health has been a pioneer in sickle cell research and treatment. Our mission is to improve the quality of life for individuals with sickle cell and reduce the prevalence and mortality of the disease.
Today, UI Health has cured 17 patients (15 with full matched donors, 2 with half-matched donors) of sickle cell disease through bone marrow transplantation (BMT) and without the need for preparative chemotherapy.
A Comprehensive Approach to Sickle Cell Disease
The Sickle Cell Program at UI Health is the largest in the Midwest, providing individualized care for pediatric, transitional, and adult patients. Our hematologists and oncologists work to help patients with health maintenance and pain management, including blood infusion and transfusion therapies and stem cell transplantation.
Patients in our Sickle Cell Program have access to a number of supportive services, including:
- Education and Outreach
- Support Groups — pediatric and adult
- National research studies